Gattex (Shire-NPS Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Gattex drug offered from Shire-NPS Pharmaceuticals, Inc.. This GLP-2 Analog [EPC],Glucagon-like Peptide-2 (GLP-2) Agonists [MoA],Glucagon-Like Peptide 2 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Shire-NPS Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | teduglutide |
| SUBSTANCE NAME: | TEDUGLUTIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | GLP-2 Analog [EPC],Glucagon-like Peptide-2 (GLP-2) Agonists [MoA],Glucagon-Like Peptide 2 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-12-21 |
| END MARKETING DATE: | 0000-00-00 |
Gattex HUMAN PRESCRIPTION DRUG Details:
| Item Description | Gattex from Shire-NPS Pharmaceuticals, Inc. |
| LABELER NAME: | Shire-NPS Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/.5mL) |
| START MARKETING DATE: | 2012-12-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68875-0101_718ce754-32c4-4ae7-87b9-50465bc5bcd7 |
| PRODUCT NDC: | 68875-0101 |
| APPLICATION NUMBER: | NDA203441 |
Other TEDUGLUTIDE Pharmaceutical Manufacturers / Labelers:
